National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Nausea and Vomiting (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 04/22/2009
Table 2. Comparison of Aprepitant and Standard Regimens

Regimen  Day 1  Days 2 and 3 
bid = twice a day.
Aprepitant Prechemotherapy: aprepitant (125 mg), ondansetron (8 mg), dexamethasone (12 mg) Aprepitant (80 mg/d)
After 8 h: ondansetron (8 mg)
Standard Prechemotherapy: ondansetron (8 mg), dexamethasone (20 mg) Ondansetron (8 mg bid)
After 8 h: ondansetron (8 mg)


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov